Elicio Therapeutics Inc
(ELTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 0 | 0 | 0 | 28,312 | 2,880 |
| Cost of Goods | N/A | N/A | N/A | 433 | 1,190 |
| Gross Profit | N/A | N/A | N/A | 27,879 | 1,690 |
| Operating Expenses | 44,986 | 35,745 | 23,733 | 67,619 | 57,153 |
| Operating Income | -44,986 | -35,745 | -23,733 | -39,307 | -55,273 |
| Interest Expense | 455 | 1,059 | 3,597 | 0 | 0 |
| Other Income | -6,457 | 1,609 | -878 | -15,266 | -24,834 |
| Pre-tax Income | -51,898 | -35,195 | -28,208 | -54,573 | -80,107 |
| Net Income Continuous | -51,898 | -35,195 | -28,208 | -54,573 | -80,107 |
| Net Income | $-51,898 | $-35,195 | $-28,208 | $-54,573 | $-80,107 |
| EPS Basic Total Ops | -4.25 | -6.96 | -89.27 | -19.30 | -54.30 |
| EPS Basic Continuous Ops | -4.25 | -6.96 | -89.27 | -19.32 | -54.27 |
| EPS Diluted Total Ops | -4.25 | -6.96 | -89.27 | -19.30 | -54.30 |
| EPS Diluted Continuous Ops | -4.25 | -6.96 | -89.27 | -19.32 | -54.27 |
| EPS Diluted Before Non-Recurring Items | -4.25 | -6.96 | -9.80 | -13.10 | -54.30 |
| EBITDA(a) | $-43,733 | $-34,575 | $-22,676 | $-36,622 | $-46,984 |